Solaxa Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 4

Solaxa General Information

Description

Developer of a biopharmaceutical company intended to provide innovative treatments to address patients with rare neurodegenerative diseases and nerve injuries caused by chemotherapy and trauma. The company offers a potent class of ion channel blockers that can detect and treat neuronal dysfunction, particularly aminopyridines, to restore nerve function, enabling users to potentially develop treatments for a wider range of neurological conditions, aiming to improve the lives of patients globally.

Contact Information

Website
www.solaxa.com
Formerly Known As
Peripheral Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7272 Wisconsin Avenue
  • Floor 9
  • Bethesda, MD 20814
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 7272 Wisconsin Avenue
  • Floor 9
  • Bethesda, MD 20814
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solaxa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) Upcoming Clinical Trials - Phase 3
1. Seed Round 31-Dec-2024 Completed Clinical Trials - Phase 2
To view Solaxa’s complete valuation and funding history, request access »

Solaxa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solaxa Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Star Ventures Angel Group
DMV Angel Group Angel Group Minority
Rochester Angel Network Angel Group Minority
TEDCO Venture Capital Minority
To view Solaxa’s complete investors history, request access »

Ready to get started?

Request a free trial

Solaxa FAQs

  • When was Solaxa founded?

    Solaxa was founded in 2021.

  • Where is Solaxa headquartered?

    Solaxa is headquartered in Bethesda, MD.

  • What is the size of Solaxa?

    Solaxa has 10 total employees.

  • What industry is Solaxa in?

    Solaxa’s primary industry is Drug Discovery.

  • Is Solaxa a private or public company?

    Solaxa is a Private company.

  • What is Solaxa’s current revenue?

    The current revenue for Solaxa is .

  • How much funding has Solaxa raised over time?

    Solaxa has raised $5M.

  • Who are Solaxa’s investors?

    Angel Star Ventures, DMV Angel Group, Rochester Angel Network, and TEDCO have invested in Solaxa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process